Medical/Pharmaceuticals

Brain Navi Begins IPO Counseling with First Securities Inc., Setting the Stage for Global MedTech Expansion

ZHUBEI, April 17, 2025 /PRNewswire/ -- Brain Navi Biotechnology Co., Ltd. (" Brain Navi") has officially begun IPO counseling with First Securities Inc., marking a strategic step toward accessing the capital markets and advancing its long-term growth in the surgical robot technology industry.

2025-04-17 12:10 3020

Duke-NUS and T Cells Diagnostics team up to simplify T-cell analysis

* Virus-specific T-cell measurement is made easier to enable better understanding of immune responses in patients and management of human infectious diseases. SINGAPORE, April 17, 2025 /PRNewswire/ -- T Cell Diagnostics Pte. Ltd. ("TCD") has licensed an intellectual property (IP) and its relat...

2025-04-17 11:05 3055

Herbalgy Unveils Touch Cool Campaign at MTR* advertising: An Immersive Installation Fusing Pain Relief with Sustainability and Innovative Design

Download high-resolution images:    https://cutt.ly/srswmUXq HONG KONG, April 17, 2025 /PRNewswire/ -- Herbalgy Pharmaceutical Ltd. is pleased to unveil its latest public engagement initiative at MTR* advertising, the leading outdoor media plat...

2025-04-17 10:00 2836

Norgine welcomes TGA registration in Australia of IFINWIL® (eflornithine) for adults and children diagnosed with high-risk neuroblastoma (HRNB)[1]

* IFINWIL®: now TGA registered in Australia * Children diagnosed with neuroblastoma are on average just 2 years old2 * The average survival rate of children with HRNB is only 50%2 UXBRIDGE, England, April 17, 2025 /PRNewswire/ -- Norgine is pleased to announce that the Australian Therapeutic...

2025-04-17 08:01 2302

Norgine strengthens rare disease portfolio with acquisition of Theravia

Acquisition of Theravia from Mérieux Equity Partners represents meaningful step forward in Norgine's strategy for sustainable growth, adding a complementary portfolio of rare disease medicines Transaction further establishes Norgine's position as a partner of choice for commercialising rare and ...

2025-04-17 08:01 2361

Saudi Arabia and France Strengthen Health Cooperation Through Strategic Agreements in Biotech and Digital Health

PARIS, April 17, 2025 /PRNewswire/ -- On the second day of an official visit to France, His Excellency Fahad Abdulrahman AlJalajel, Minister of Health of the Kingdom of Saudi Arabia, held bilateral meetings with senior French officials including Minister for Labour, Health, Solidarity and Familie...

2025-04-17 06:21 3241

Henlius 2025 Global R&D Day: Harnessing the Power of Innovation to Propel Global Strategy to New Heights

SHANGHAI, April 16, 2025 /PRNewswire/ -- Henlius (2696.HK) held its 2025 Global R&D Day under the theme of "Collaborate to Create". Senior executives from Henlius gathered with leading experts, scholars, and heads of innovation from across the industry to engage in in-depth discussions on the lat...

2025-04-16 23:30 3226

Transforming Lives with TAVI: A Milestone in Aortic Stenosis Treatment

MANILA, Philippines, April 16, 2025 /PRNewswire/ -- The Philippine Heart Center has reached a significant milestone by successfully performing six Transcatheter Aortic Valve Implantation (TAVI) procedures in a single day. This groundbreaking technique offers a minimally invasive alternative to op...

2025-04-16 20:32 2641

Global Health Innovators recognised with Abu Dhabi Global Health Week Innovation Awards for transformative impact

* Winners of the ADGHW Innovation Awards 2025 addressed prenatal gene editing, robotic organ transplantation, precision drug delivery, and novel pain treatments * Recipients include the Children's Hospital of Philadelphia, University of Pennsylvania, King Faisal Specialist Hospital & Research...

2025-04-16 20:15 2602

Fullerton Health Indonesia Launches First Executive Health Screening Centre Offering Exclusive, Private and Customised Screening in Jakarta

JAKARTA, Indonesia, April 16, 2025 /PRNewswire/ -- Fullerton Health Indonesia today officially launched its first Executive Health Screening Centre (EHS) in Jakarta, the fifth such centre in the Fullerton Health Group's executive health screening portfolio acrossAsia. The 700-square metre centre o...

2025-04-16 14:00 2957

The Lancet Child & Adolescent Health Publishes Phase III Trial and 24-Month Follow-Up Results of Ziresovir for RSV in Infants Under 6 Months

SHANGHAI, April 16, 2025 /PRNewswire/ -- The Lancet Child & Adolescent Health, a leading international journal in pediatric and adolescent medicine, has published the Phase III clinical trial results ofziresovir, a novel RSV-targeted antiviral drug developed by Shanghai Ark Biopharmaceutical Ltd....

2025-04-16 09:00 3388

IPAX-Linz Study Reports Promising Efficacy for TLX101 Glioma Therapy Candidate

MELBOURNE, Australia and INDIANAPOLIS, April 16, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces preliminary results from the Phase 2 IPAX-Linz study of TLX101 (131 I-iodofalan[1]) in recurrent high-grade glioma (brain cancer), substan...

2025-04-16 06:45 2484

Vantage Foundation Visits SOS Children's Villages Portugal: Addressing Neglect and Breaking the Cycle

LISBON, Portugal, April 15, 2025 /PRNewswire/ -- Neglect is one of the most pervasive yet overlooked threats to a child's well-being. Unlike abandonment, neglect often goes unnoticed—leaving children trapped in cycles of chronic emotional harm, broken trust, and long-term developmental struggles....

2025-04-15 17:05 3416

Open nominations for the BIAL Award in Biomedicine 2025 with an increased amount to €350,000

Created to distinguish the most remarkable scientific discoveries in the biomedical field, this international award has been granted a growing reputation as a prelude to the Nobel Prize since it has distinguished in a former edition two authors subsequently honoured with the Nobel Prize in Medic...

2025-04-15 15:00 2396

Wang Qunbin: Leveraging Innovation and Global Operational Strengths to Contribute "Fosun Power" to the Development of Hainan Free Trade Port

HONG KONG and SHANGHAI, April 15, 2025 /PRNewswire/ -- On April 14, the 2025 Hainan Free Trade Port Global Investment Promotion Conference was held inHaikou . Jointly hosted by the People's Government ofHainan Province and the Ministry of Commerce, the conference is one of the key events in the 20...

2025-04-15 12:05 3406

Chromatin Bioscience Signs Collaboration Agreement with Astellas

EDINBURGH, Scotland, April 14, 2025 /PRNewswire/ -- Chromatin Bioscience, a leader in the design of synthetic promoters and gene control systems, is pleased to announce a collaboration agreement with Astellas Pharma , a global life sciences company. Under the agreement...

2025-04-14 17:00 2764

CMEF Shanghai 2025 Wraps Up in Shanghai with Record-Breaking Innovations and Global Participation

SHANGHAI, April 14, 2025 /PRNewswire/ -- The 91st China International Medical Equipment Fair (CMEF) concluded onApril 11, 2025, in Shanghai, after featuring groundbreaking medical technologies from nearly 5,000 exhibitors and attracting hundreds of thousands of attendees from more than 150 countr...

2025-04-14 10:53 3731

Over 3 million children died from AMR-related infections in 2022, major study shows

A landmark study presented today at ESCMID Global 2025 has revealed that over 3 million children worldwide lost their lives in 2022 due to antimicrobial resistance (AMR)-related infections. VIENNA, April 12, 2025 /PRNewswire/ -- The study underscores the urgent need for both regional and global...

2025-04-13 06:01 3510

Clinical research results for Kelun-Biotech's TROP2 ADC sacituzumab tirumotecan (sac-TMT) published in Nature Medicine, a top international medical journal

CHENGDU, China, April 12, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") today announced that results from a Phase 3 registrational clinical study evaluating the novel TROP2 antibody drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT) for the treatment o...

2025-04-12 17:20 4413

Patrick Tan appointed as Duke-NUS Dean to lead next era of medical innovation and education

SINGAPORE, April 11, 2025 /PRNewswire/ -- Duke-NUS Medical School has appointed ProfessorPatrick Tan as its next and fourth Dean, effective 1 January 2026, marking a new chapter for the School as it builds on its legacy of medical education, research and innovation. Prof Tan will serve as Dean-de...

2025-04-11 20:06 4453
1 ... 58596061626364 ... 395